相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Chen Zhao et al.
BJU INTERNATIONAL (2011)
LHRH Antagonist Cetrorelix Reduces Prostate Size and Gene Expression of Proinflammatory Cytokines and Growth Factors in a Rat Model of Benign Prostatic Hyperplasia
Ferenc G. Rick et al.
PROSTATE (2011)
The physiological function of lower urinary tract smooth muscle
C. H. Fry et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2010)
Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix
Agnieszka Siejka et al.
BJU INTERNATIONAL (2010)
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
Christopher Chapple
CURRENT OPINION IN UROLOGY (2010)
Attenuated Proliferation and Trans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2010)
Transient Receptor Potential A1 and Cannabinoid Receptor Activity in Human Normal and Hyperplastic Prostate: Relation to Nerves and Interstitial Cells
Christian Gratzke et al.
EUROPEAN UROLOGY (2010)
Emerging drugs for the treatment of benign prostatic obstruction
Hashim Hashim et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
alpha(1)-Adrenoceptor pharmacome: alpha(1L)-Adrenoceptor and alpha(1A)-adrenoceptor in the lower urinary tract
Atsushi Nishimune et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Identification of Cysteine-Rich Epidermal Growth Factor-Like Domain 1α (CRELD1α) as a Novel α1A-Adrenoceptor-Down-Regulating Protein and Establishment of an α1L-Adrenoceptor-Expressing Cell Line
Atsushi Nishimune et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
The Residual Nonadrenergic Contractile Response to Nerve Stimulation of the Mouse Prostate Is Mediated by Acetylcholine but Not ATP in a Comparison with the Mouse Vas Deferens
Carl W. White et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
Benedetta Fibbi et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Roger Dmochowski et al.
JOURNAL OF UROLOGY (2010)
Characterisation of the prostanoid receptor mediating inhibition of smooth muscle contractility in the rat prostate gland
Slavko Tokanovic et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Antimuscarinics and Bladder Outlet Obstruction: From a Contraindication to an Indication?
Anastasios Athanasopoulos
NEUROUROLOGY AND URODYNAMICS (2010)
Dose-ranging Study of the Luteinizing Hormone-releasing Hormone Receptor Antagonist Cetrorelix Pamoate in the Treatment of Patients With Symptomatic Benign Prostatic Hyperplasia
Frans Debruyne et al.
UROLOGY (2010)
Expression of cAMP-dependent Protein Kinase Isoforms in the Human Prostate: Functional Significance and Relation to PDE4
Eginhard Waldkirch et al.
UROLOGY (2010)
Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction
Altug Tuncel et al.
WORLD JOURNAL OF UROLOGY (2010)
Expression and function of G-protein-coupled receptors in the male reproductive tract
Maria Christina W. Avellar et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2009)
Inositol trisphosphate-dependent Ca2+ stores and mitochondria modulate slow wave activity arising from the smooth muscle cells of the guinea pig prostate gland
Betty Exintaris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue
Stephanie Oger et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Spontaneous Electrical Waveforms in Aging Guinea Pig Prostates
Anupa Dey et al.
JOURNAL OF UROLOGY (2009)
Clinical and Experimental Aspects of Adreno-Muscarinic Synergy in the Bladder Base and Prostate
Alexander Roosen et al.
NEUROUROLOGY AND URODYNAMICS (2009)
Established Medical Therapy for Benign Prostatic Hyperplasia
Gregory B. Auffenberg et al.
UROLOGIC CLINICS OF NORTH AMERICA (2009)
The α1A-adrenoceptor gene is required for the α1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate
K. T. Gray et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Identification of α1L-adrenoceptor in mice and its abolition by α1A-adrenoceptor gene knockout
I. Muramatsu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Targeted disruption of the A2A adenosine receptor reduces in-vitro prostate contractility in mature mice
Katherine T. Gray et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia
Frans Debruyne et al.
EUROPEAN UROLOGY (2008)
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
Christian G. Stief et al.
EUROPEAN UROLOGY (2008)
Cholinergic innervation and muscarinic receptors in the human prostate
Lambertus P. W. Witte et al.
EUROPEAN UROLOGY (2008)
Isoflavone attenuates vascular contraction through inhibition of the RhoA/Rho-kinase signaling pathway
Young Mi Seok et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Prostate growth and inflammation
Alessandro Sciarra et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
Claus G. Roehrborn et al.
JOURNAL OF UROLOGY (2008)
Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia
Patrick J. Gallegos et al.
PHARMACOTHERAPY (2008)
Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity
Kevin T. McVary et al.
UROLOGY (2008)
Inflammation and chronic prostatic diseases: Evidence for a link?
Alessandro Sciarra et al.
EUROPEAN UROLOGY (2007)
cGMP-enhancing- and αIA/αID-adrenoreceptor blockade-derived inhibition of Rho-kinase by KMUP-I provides optimal prostrate relaxation and epithelial cell anti-proliferation efficacy
Chi-Ming Liu et al.
PROSTATE (2007)
Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction
Steven A. Kaplan et al.
EUROPEAN UROLOGY (2007)
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Gero Kramer et al.
EUROPEAN UROLOGY (2007)
Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally
Taiji Tsukamoto et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
Kevin T. McVary et al.
JOURNAL OF UROLOGY (2007)
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder
Annamaria Morelli et al.
PROSTATE (2007)
RhoA/Rho kinase-mediated Ca2+ sensitization in the contraction of human prostate
Ryosuke Takahashi et al.
NEUROUROLOGY AND URODYNAMICS (2007)
Stimulation of epithelial CB1 receptors inhibits contractions of the rat prostate gland
S. Tokanovic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries
Annie Hutchison et al.
EUROPEAN UROLOGY (2007)
Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized, double-blind trial
Kevin T. McVary et al.
JOURNAL OF UROLOGY (2007)
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology:: Present and future
Stefan Ueckert et al.
EUROPEAN UROLOGY (2006)
α1L-adrenoceptors mediate contractions of the isolated mouse prostate
Katherine T. Gray et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Spontaneous electrical activity in the prostate gland
Betty Exintaris et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2006)
In vitro functional responses of isolated normal human prostatic tissue to compounds interacting with the cyclic guanosine monophosphate pathway
Giorgi Kedia et al.
UROLOGY (2006)
The effect of histamine on field-stimulated contractions of the guinea-pig prostate
Karen P. Kerr
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
The purinergic component of human vas deferens contraction
FCL Banks et al.
FERTILITY AND STERILITY (2006)
Protein kinase G-induced activation of KATP channels reduces contractility of human prostate tissue
JM Haynes et al.
PROSTATE (2006)
Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
P Abrams et al.
JOURNAL OF UROLOGY (2006)
Inhibitors of 5 alpha-reductase in the treatment of benign prostatic hyperplasia
TH Tarter et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: A randomized clinical trial
E Colli et al.
EUROPEAN UROLOGY (2006)
Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors
I Muramatsu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men
CA Holden et al.
LANCET (2005)
Identification of c-kit-positive cells in the human prostate: The interstitial cells of Cajal
A Shafik et al.
ARCHIVES OF ANDROLOGY (2005)
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells:: synthesis of new transporter inhibitors as tools for this study
L Ruiz-Llorente et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells
ALM Cook et al.
CELLULAR SIGNALLING (2004)
Adenosine 5′-triphosphate and noradrenaline are excitatory cotransmitters to the fibromuscular stroma of the guinea pig prostate gland
R Buljubasich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Characterization of the ion channel currents in single myocytes of the guinea pig prostate
RJ Lang et al.
JOURNAL OF UROLOGY (2004)
High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor
D Ramsay et al.
MOLECULAR PHARMACOLOGY (2004)
A(1) and A(2A) adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells
A Preston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Ca2+ currents in smooth muscle cells isolated from human prostate
GP Sui et al.
PROSTATE (2004)
Interstitial cells in the human prostate: A new therapeutic target?
F Van der Aa et al.
PROSTATE (2003)
Lower urinary tract symptoms/benign prostatic hyperplasia: Minimizing morbidity caused by treatment
CC Schulman
UROLOGY (2003)
被撤回的出版物: Pharmacological characterization of isolated human prostate (Retracted Article. See vol 170, pg 2394, 2003)
RR Kester et al.
JOURNAL OF UROLOGY (2003)
Adenosine 5′-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland
L Ventura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The role of dihydrotestosterone in benign prostatic hyperplasia
C Carson et al.
UROLOGY (2003)
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland
L Ruiz-Llorente et al.
PROSTATE (2003)
Ion-channel currents of smooth muscle cells isolated from the prostate of guinea-pig
SJ Oh et al.
BJU INTERNATIONAL (2003)
Y-27632 a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells
RW Rees et al.
JOURNAL OF UROLOGY (2003)
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
P Rigatti et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2003)
Sildenafil influences lower urinary tract symptoms
K Sairam et al.
BJU INTERNATIONAL (2002)
Protein kinase G activation of KATP channels in human-cultured prostatic stromal cells
ALM Cook et al.
CELLULAR SIGNALLING (2002)
Knockout of the α1A/C-adrenergic receptor subtype:: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure
DG Rokosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Spontaneous slow wave and contractile activity of the guinea pig prostate
B Exintaris et al.
JOURNAL OF UROLOGY (2002)
Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: Sildenafil and papaverin generate inhibition
PI Adolfsson et al.
PROSTATE (2002)
Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate
S Ückert et al.
JOURNAL OF UROLOGY (2001)
Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia
MD Eckhardt et al.
UROLOGY (2001)
β2-adrenoceptor-mediated inhibition of field stimulation induced contractile responses of the smooth muscle of the rat prostate gland
PJ Kalodimos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men
JB Meigs et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
MD Eckhardt et al.
UROLOGY (2001)
Lower urinary tract symptoms: What are the implications for the patients?
RM Scarpa
EUROPEAN UROLOGY (2001)
Interactions between prostate volume, filling cystometric estimated parameters, and data from, pressure-flow studies in 565 men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
MD Eckhardt et al.
NEUROUROLOGY AND URODYNAMICS (2001)
Species differences in the actions of sensory neuropeptides on contractility of the smooth muscle of the rat and guinea-pig prostate
S Ventura et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat
A Preston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression
K Yuasa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Calcitonin gene-related peptide (CGRP) inhibits contractions of the prostatic stroma of the rat but not the guinea-pig
S Ventura et al.
REGULATORY PEPTIDES (2000)
Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland
WAK Lau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Splice isoforms of α1a-adrenoceptor in rabbit
F Suzuki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
P2X receptor immunoreactivity in the male genital organs of the rat
HY Lee et al.
CELL AND TISSUE RESEARCH (2000)
Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors
K Mulryan et al.
NATURE (2000)
The contractile effects of endothelins on the smooth muscle of the rat prostate gland
A Salamoussa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
